Humacyte Statistics
NASDAQ: HUMAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.4723-0.0057 (-1.19%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Humacyte by the numbers
Humacyte has a market capitalization of $131.2 million based on 277.80M shares outstanding. With trailing EPS of $-0.51, Humacyte is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.8% below its 50-day average and 45.5% below its 200-day average.
Average daily trading volume is 6.35M shares, or about $3.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
HUMA valuation vs. peer median
| Metric | HUMA | Peer median | Difference |
|---|---|---|---|
| Market cap | $131.20M | $141.74M | -7% |
| Avg. volume | 6.35M | 798.71K | +695% |
Peer median across 8 companies: ARMP, AVXL, OTLK, MOLN, TNYA, ENGN, LENZ, ABOS.
Valuation
- Market cap
- $131.20M
- EPS (TTM)
- $-0.51
- Shares outstanding
- 277.80M
Price and trading
- Previous close
- 0.478
- Open
- 0.4798
- Day range
- 0.46 – 0.4799
- 52-week range
- 0.46 – 1.90
- 52-week change
- -71.29%
- 50-day moving average
- 0.6118
- 200-day moving average
- 0.8669
- Beta
- —
- Volume
- 3.91M
- Average volume
- 6.35M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2026
Additional statistics
- Market Cap
- 131.20M
- Forward Pe
- -1.91
- Eps
- -0.51
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.90
- Week52 Low
- 0.46
- Avg Volume
- 6.35M
- Shares Outstanding
- 277.80M
- Ma50
- 0.61
- Ma200
- 0.87
- Earnings Date
- Aug 12, 2026
- Pct From52w High
- -75.08%
- Pct From52w Low
- 2.67%